Erna C van Balen1, Marian Krawczyk2,3,4, Deborah Gue5, Shannon Jackson5, Samantha C Gouw1,6, Johanna G van der Bom1,7, Richard Sawatzky3,4,8. 1. Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands. 2. Lord Kelvin Adam Smith Fellow, School of Interdisciplinary Studies, University of Glasgow, Glasgow, UK. 3. School of Nursing, Trinity Western University, Langley, Canada. 4. Centre for Health Evaluation & Outcome Sciences, Providence Health Care Research Institute, Vancouver, Canada. 5. British Columbia Provincial Bleeding Disorders Program - Adult Division, St. Paul's Hospital, Vancouver, Canada. 6. Department of Pediatric Hematology, Emma Children's Hospital, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands. 7. Sanquin Research, Center for Clinical Transfusion Research, Leiden, The Netherlands. 8. Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Abstract
INTRODUCTION AND AIM: The British Columbia Adult Haemophilia Team recently adopted a patient-centred care approach. The team presented visual information on an individual's pharmacokinetic profile and bleed history and encouraged patients to participate in treatment decisions. This qualitative study explored how this approach changed patients' understanding of haemophilia and how it facilitated them to make treatment decisions. METHODS: We interviewed 18 males with mild, moderate or severe haemophilia, using a convenience sample from the adult haemophilia clinic at St. Paul's hospital in Vancouver, Canada. Interviews were recorded and transcribed verbatim and analyzed using descriptive content analysis. RESULTS: Most participants reported that reviewing visual information with the Clinic Team helped them in their communication with their care providers during their annual review clinic appointment. Despite this improved communication, for some the most important feature of their treatment was that they had switched from on-demand treatment to prophylactic treatment in recent years and were able to prevent bleeds. Almost half of the participants reported that the visual information presented increased their understanding of haemophilia and the pharmacokinetics of coagulation factor. Three patients improved their treatment adherence or had changed their prophylaxis schedules based on this. Most participants felt that they were involved in decision-making about their treatment schedule, which they appreciated. On the other hand, two participants thought the Clinic Team should make these decisions. CONCLUSION: Participants perceived the patient-centred prophylaxis approach helpful because it enhanced communication with the Clinic Team, increased their understanding of haemophilia and pharmacokinetics of coagulation factor and facilitated treatment decisions.
INTRODUCTION AND AIM: The British Columbia Adult Haemophilia Team recently adopted a patient-centred care approach. The team presented visual information on an individual's pharmacokinetic profile and bleed history and encouraged patients to participate in treatment decisions. This qualitative study explored how this approach changed patients' understanding of haemophilia and how it facilitated them to make treatment decisions. METHODS: We interviewed 18 males with mild, moderate or severe haemophilia, using a convenience sample from the adult haemophilia clinic at St. Paul's hospital in Vancouver, Canada. Interviews were recorded and transcribed verbatim and analyzed using descriptive content analysis. RESULTS: Most participants reported that reviewing visual information with the Clinic Team helped them in their communication with their care providers during their annual review clinic appointment. Despite this improved communication, for some the most important feature of their treatment was that they had switched from on-demand treatment to prophylactic treatment in recent years and were able to prevent bleeds. Almost half of the participants reported that the visual information presented increased their understanding of haemophilia and the pharmacokinetics of coagulation factor. Three patients improved their treatment adherence or had changed their prophylaxis schedules based on this. Most participants felt that they were involved in decision-making about their treatment schedule, which they appreciated. On the other hand, two participants thought the Clinic Team should make these decisions. CONCLUSION:Participants perceived the patient-centred prophylaxis approach helpful because it enhanced communication with the Clinic Team, increased their understanding of haemophilia and pharmacokinetics of coagulation factor and facilitated treatment decisions.
Authors: Karen Beny; Benjamin du Sartz de Vigneulles; Valerie Chamouard; Ronald Guilloux; Valérie Gay; Claude Negrier; Claude Dussart Journal: Patient Prefer Adherence Date: 2021-08-18 Impact factor: 2.711
Authors: Karen Beny; Amélie Dubromel; Benjamin du Sartz de Vigneulles; Valérie Gay; Florence Carrouel; Claude Negrier; Claude Dussart Journal: PLoS One Date: 2022-09-09 Impact factor: 3.752
Authors: Matteo Nicola Dario Di Minno; Mariasanta Napolitano; Anna Chiara Giuffrida; Erminia Baldacci; Christian Carulli; Elena Boccalandro; Clarissa Bruno; Eleonora Forneris; Irene Ricca; Walter Passeri; Marco Martinelli; Gianna Franca Rivolta; Luigi Piero Solimeno; Carlo Martinoli; Angiola Rocino; Gianluigi Pasta Journal: Br J Haematol Date: 2021-12-19 Impact factor: 8.615
Authors: Karen Beny; Benjamin du Sartz de Vigneulles; Florence Carrouel; Denis Bourgeois; Valérie Gay; Claude Negrier; Claude Dussart Journal: Int J Environ Res Public Health Date: 2022-01-06 Impact factor: 3.390